Therapeutic Options in Refractory Diabetic Macular Oedema Sanket U. ShahRaj K. Maturi Current Opinion 15 February 2017 Pages: 481 - 492
Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis Bruno GelonezeJosé Carlos de Lima-JúniorLício A. Velloso Leading Article Open access 23 February 2017 Pages: 493 - 503
Immunomodulatory Drugs in Multiple Myeloma: Mechanisms of Action and Clinical Experience Sarah A. HolsteinPhilip L. McCarthy Review Article 16 February 2017 Pages: 505 - 520
JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects Shubhasree BanerjeeAnn BiehlDaniella M. Schwartz Review Article 03 March 2017 Pages: 521 - 546
The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus David A. JohnsonPhilip O. KatzDonald O. Castell Review Article Open access 23 February 2017 Pages: 547 - 561
Delta-9-Tetrahydrocannabinol/Cannabidiol Oromucosal Spray (Sativex®): A Review in Multiple Sclerosis-Related Spasticity Gillian M. Keating Adis Drug Evaluation 14 March 2017 Pages: 563 - 574
Fluocinolone Acetonide Intravitreal Implant 0.19 mg (ILUVIEN®): A Review in Diabetic Macular Edema Yahiya Y. Syed Adis Drug Evaluation 10 March 2017 Pages: 575 - 583
Plecanatide: First Global Approval Zaina T. Al-SalamaYahiya Y. Syed AdisInsight Report 03 March 2017 Pages: 593 - 598
